These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30419316)

  • 21. Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology.
    Deveson IW; Gong B; Lai K; LoCoco JS; Richmond TA; Schageman J; Zhang Z; Novoradovskaya N; Willey JC; Jones W; Kusko R; Chen G; Madala BS; Blackburn J; Stevanovski I; Bhandari A; Close D; Conroy J; Hubank M; Marella N; Mieczkowski PA; Qiu F; Sebra R; Stetson D; Sun L; Szankasi P; Tan H; Tang LY; Arib H; Best H; Burgher B; Bushel PR; Casey F; Cawley S; Chang CJ; Choi J; Dinis J; Duncan D; Eterovic AK; Feng L; Ghosal A; Giorda K; Glenn S; Happe S; Haseley N; Horvath K; Hung LY; Jarosz M; Kushwaha G; Li D; Li QZ; Li Z; Liu LC; Liu Z; Ma C; Mason CE; Megherbi DB; Morrison T; Pabón-Peña C; Pirooznia M; Proszek PZ; Raymond A; Rindler P; Ringler R; Scherer A; Shaknovich R; Shi T; Smith M; Song P; Strahl M; Thodima VJ; Tom N; Verma S; Wang J; Wu L; Xiao W; Xu C; Yang M; Zhang G; Zhang S; Zhang Y; Shi L; Tong W; Johann DJ; Mercer TR; Xu J;
    Nat Biotechnol; 2021 Sep; 39(9):1115-1128. PubMed ID: 33846644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid biopsy: unlocking the potentials of cell-free DNA.
    Chu D; Park BH
    Virchows Arch; 2017 Aug; 471(2):147-154. PubMed ID: 28466157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumoral DNA: Preanalytical validation and quality control in a diagnostic laboratory.
    Nikolaev S; Lemmens L; Koessler T; Blouin JL; Nouspikel T
    Anal Biochem; 2018 Feb; 542():34-39. PubMed ID: 29137972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.
    Creemers A; Krausz S; Strijker M; van der Wel MJ; Soer EC; Reinten RJ; Besselink MG; Wilmink JW; van de Vijver MJ; van Noesel CJM; Verheij J; Meijer SL; Dijk F; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):394-403. PubMed ID: 28801248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC's Analytical Variables Working Group.
    Godsey JH; Silvestro A; Barrett JC; Bramlett K; Chudova D; Deras I; Dickey J; Hicks J; Johann DJ; Leary R; Lee JSH; McMullen J; McShane L; Nakamura K; Richardson AO; Ryder M; Simmons J; Tanzella K; Yee L; Leiman LC
    Clin Chem; 2020 Sep; 66(9):1156-1166. PubMed ID: 32870995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continual Improvement of the Reliability of Next-Generation Sequencing-Based ctDNA Analysis: A Long-Term Comparison of ctDNA Detection in China.
    Peng R; Zhang R; Li J
    Clin Chem; 2022 Jul; 68(7):940-952. PubMed ID: 35687601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opportunities of circulating tumor DNA in lung cancer.
    Wu TH; Hsiue EH; Yang JC
    Cancer Treat Rev; 2019 Aug; 78():31-41. PubMed ID: 31326635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies.
    Gorgannezhad L; Umer M; Islam MN; Nguyen NT; Shiddiky MJA
    Lab Chip; 2018 Apr; 18(8):1174-1196. PubMed ID: 29569666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating Tumor DNA: A Step into the Future of Cancer Management.
    Fernandes Marques J; Pereira Reis J; Fernandes G; Hespanhol V; Machado JC; Costa JL
    Acta Cytol; 2019; 63(6):456-465. PubMed ID: 30852572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current situation and prospect of breast cancer liquid biopsy].
    Zhou B; Xin L; Xu L; Ye JM; Liu YH
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):106-109. PubMed ID: 29397622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Next-generation sequencing in liquid biopsy: cancer screening and early detection.
    Chen M; Zhao H
    Hum Genomics; 2019 Aug; 13(1):34. PubMed ID: 31370908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
    Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
    Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of circulating tumor DNA in the management of early-stage lung cancer.
    Zhao H; Chen KZ; Hui BG; Zhang K; Yang F; Wang J
    Thorac Cancer; 2018 May; 9(5):509-515. PubMed ID: 29528556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
    Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
    Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
    [No Abstract]   [Full Text] [Related]  

  • 36. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
    Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
    Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group.
    Shulman DS; Klega K; Imamovic-Tuco A; Clapp A; Nag A; Thorner AR; Van Allen E; Ha G; Lessnick SL; Gorlick R; Janeway KA; Leavey PJ; Mascarenhas L; London WB; Vo KT; Stegmaier K; Hall D; Krailo MD; Barkauskas DA; DuBois SG; Crompton BD
    Br J Cancer; 2018 Aug; 119(5):615-621. PubMed ID: 30131550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating-tumor DNA as an early detection and diagnostic tool.
    Butler TM; Spellman PT; Gray J
    Curr Opin Genet Dev; 2017 Feb; 42():14-21. PubMed ID: 28126649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high-throughput protocol for isolating cell-free circulating tumor DNA from peripheral blood.
    Pandoh PK; Corbett RD; McDonald H; Alcaide M; Kirk H; Trinh E; Haile S; MacLeod T; Smailus D; Bilobram S; Mungall AJ; Ma Y; Moore RA; Coope R; Zhao Y; Jones SJ; Holt RA; Karsan A; Morin RD; Marra MA
    Biotechniques; 2019 Feb; 66(2):85-92. PubMed ID: 30744412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Circulating Tumor DNA (ctDNA) Detection Using BEAMing and Its Clinical Significance.].
    Nakamura K
    Rinsho Byori; 2016 May; 64(4):400-406. PubMed ID: 29182806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.